The Dow's Dividend Giants: Yield Isn't Everything

The Dogs of the Dow aren't always ready to perform.

May 18, 2014 at 9:05AM

Dividends are important, and one of the best things about the Dow Jones Industrials (DJINDICES:^DJI) is that every one of the 30 component stocks that make up the Dow pay a dividend. But when it comes to dividends, it is possible to have too much of a good thing if you simply pick stocks with the highest yields without considering any other factors. Let's look at one strategy that does exactly that and examine some of its shortcomings, including its emphasis on telecoms AT&T (NYSE:T) and Verizon (NYSE:VZ) and pharma stocks Merck (NYSE:MRK) and Pfizer (NYSE:PFE).

Source: Tax Credits, Flickr.

Who let the Dogs out?
The popular Dogs of the Dow strategy does exactly what many dividend investors do: aim for the highest-yielding portfolio possible. Under the strategy, you choose the top-yielding stocks in the Dow Jones Industrials at the beginning of the year and hold onto them throughout the year, replacing them with the next crop of high-yield stocks the following year.

The Dogs of the Dow did extremely well last year, outperforming the Dow Jones Industrials by about four percentage points. But unfortunately, that track record hasn't been consistent. In 11 of the past 18 years, it has underperformed the Dow itself.

Part of the reason for the Dogs of the Dow's performance is that the same stocks tend to top the list each year. For instance, AT&T and Verizon have once again been named the top two Dogs of the Dow for 2014, marking the fifth consecutive year they've led the list. Moreover, looking further back at history, telecom stocks have consistently been among the top yielders of the Dow over the years.


But both AT&T and Verizon have much different businesses than they did when they joined the Dow. The days of utility-like legacy landlines are largely over, and both Verizon and AT&T have now become primarily mobile network giants, requiring huge capital outlays to support their growth. Recently, that has worked out well for AT&T and Verizon, as the revolution in mobile devices has given them pricing power almost to name their own price for data plans. Yet unlike their landline networks, which served them well for generations, mobile networks that adequately handled customer loads for a short period can become obsolete in the blink of an eye as new devices continually test their limits. Moreover, an imminent price war from smaller operators could destroy the competitive advantage that AT&T and Verizon have had for years, especially since neither Verizon nor AT&T have a substantial international presence.

Meanwhile, big pharma stocks Pfizer and Merck have been among the top five Dow Dogs for the past four years, as well as at various times in past years. Yet current high yields reflect vast uncertainty about their future. Investors foresaw years in advance that both Pfizer and Merck would have blockbuster drugs coming off patent, and share prices fell in light of that uncertainty, boosting dividend yields. These companies have seen their share prices stay relatively strong despite the huge revenues they've lost to generic competition. Yet the challenges in getting new drugs approved have plagued both Merck and Pfizer recently, forcing the companies to accept setbacks from time to time. Eventually, both companies will likely find new blockbuster prospects. But until then, dividend investors will have to be careful to make sure earnings stay high enough to sustain their payouts.

It's tempting to look at the highest-yielding stocks in the Dow Jones Industrials as sure things. But relying solely on yields can create a big trap if you're not careful.

Top dividend stocks for the next decade
The smartest investors know that dividend stocks simply crush their non-dividend-paying counterparts over the long term. That's beyond dispute. They also know that a well-constructed dividend portfolio creates wealth steadily, while still allowing you to sleep like a baby. Knowing how valuable such a portfolio might be, our top analysts put together a report on a group of high-yielding stocks that should be in any income investor's portfolio. To see our free report on these stocks, just click here now.

Dan Caplinger and The Motley Fool have no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.

Compare Brokers